Is Bipolar Disorder Genetic? Family History and Heritability Explained
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder has a substantial genetic component. Family, twin, and genomic research show that inherited differences strongly influence susceptibility. Yet having a parent, sibling, or child with bipolar disorder never determines that another relative will develop it. Families share combinations of genetic vulnerabilities, life circumstances, and other influences, while individual clinical outcomes remain variable. The central question is therefore how genetic susceptibility changes probability and how that evidence can help people make sound clinical decisions.
Studies commonly estimate the heritability of bipolar disorder at approximately 60%–80%. This is a population-level estimate of variation in underlying liability, not a percentage chance that the child of an affected parent will develop bipolar disorder. The distinction is crucial. The 2025 Nature study of bipolar genetics confirms a complex genetic architecture, and the National Institute of Mental Health (NIMH) explains that many genes are involved and even identical twins can have different outcomes.
This article examines familial transmission, absolute and relative risk, twin studies, genetic variants, bipolar I and bipolar II, polygenic risk scores, genetic testing, environmental factors, family planning, early signs, and the appropriate role of family history in psychiatric assessment. The aim is to interpret the evidence precisely, recognizing what modern research establishes and where individual prediction remains uncertain.
For additional clinical context, see Bipolar Disorder and the Brain: What Neuroscience Can and Cannot Explain.
Is bipolar disorder hereditary?
Yes. Bipolar disorder often clusters within families, and relatives of affected people have a higher average risk than people without an affected close relative. This familial pattern is observed in population registries, clinical family studies, studies that follow children of affected parents, and twin research. It is also supported by genetic associations discovered in large international samples.
The condition usually follows a complex or polygenic inheritance pattern: many genetic variants each contribute small changes in susceptibility, while additional factors shape whether the disorder develops and how it progresses. There is no single gene that explains most ordinary cases. The U.S. National Library of Medicine states that first-degree relatives have an increased risk and that most people with an affected close relative will not develop bipolar disorder themselves.
Familial clustering and genetic inheritance are related but different concepts. Family members may also share sleep patterns, stressful circumstances, access to healthcare, cultural interpretations of distress, and other exposures. Researchers use twin designs, genomic studies, and adjusted epidemiological comparisons to investigate these overlapping contributions. Evidence for substantial genetic influence is strong; the effect of any particular inherited variant on one individual's future is generally small O'Connell et al., 2025.
What does heritability mean?
Heritability describes the proportion of variation in a trait or underlying liability within a particular population that statistical models attribute to genetic differences among individuals. For bipolar disorder, the often cited 60%–80% range refers to variation in susceptibility across studied populations. A value in this range does not mean that DNA causes 80% of one person's illness or that environmental conditions cause exactly the remaining 20%.
Heritability is also distinct from penetrance, the probability that a person carrying a particular genotype develops a phenotype. A complex disorder usually cannot be represented by the penetrance of one variant, because susceptibility is distributed across many variants and contexts. Genetic associations also need to be distinguished from causal biological mechanisms, which require independent investigation.
Heritability estimates are influenced by study populations, diagnostic definitions, model assumptions, environmental distributions, and the ways individuals are assessed. A high heritability estimate can coexist with important modifiable risk factors, useful treatments, and divergent outcomes among genetically similar relatives. The 2025 multi-ancestry Nature analysis cites the 60%–80% conventional range while documenting the considerable genetic complexity still being explored.
Why 80% heritability does not mean an 80% chance for a child
An individual child's chance of developing a diagnosis is an absolute risk. A population heritability estimate has a different denominator and answers a different question. Converting one directly into the other is statistically invalid. For example, the fact that a trait is highly heritable does not show that every close relative of an affected person crosses the diagnostic threshold.
A child's absolute risk is estimated from research that follows offspring, not from the percentage of population variation attributed to genetics. Such estimates depend on how long offspring are observed and how diagnoses are confirmed. A child who is assessed only at age 12 has had less opportunity to experience a condition that commonly emerges in adolescence or adulthood than someone followed to age 35. The large 2023 World Psychiatry family-risk meta-analysis illustrates how study design changes the observed probabilities.
Heritability, relative risk, absolute risk, and genetic correlation
Relative risk compares how often an outcome occurs in one group against another. Absolute risk describes the percentage of a defined group who experience the outcome during a specified period. Heritability concerns population variation in liability. Genetic correlation concerns the extent to which inherited influences on two traits overlap. These measures should never be used as synonyms.
For example, a fivefold relative risk can coexist with a relatively low absolute risk when the outcome is uncommon in the comparison population. Similarly, substantial shared genetic influences between bipolar disorder and depression do not establish that the two diagnoses are clinically interchangeable. Every estimate needs its study population, time horizon, outcome definition, and uncertainty Uher et al., 2023, O'Connell et al., 2025.
How much does a parent with bipolar disorder increase risk?
The most useful estimates come from longitudinal offspring research and registry comparisons. A major 2023 meta-analysis in World Psychiatry assembled 211 studies involving children of parents with a range of psychiatric conditions. Among offspring of parents with bipolar disorder, the pooled relative risk of developing bipolar disorder was approximately 5.1 compared with offspring of parents without the condition.
Across the diverse studies contributing to that bipolar-specific estimate, approximately 5% of offspring of affected parents received the same diagnosis, compared with about 1% of comparison offspring. In a sensitivity analysis restricted to prospective studies that followed offspring at least to the typical age of onset, the bipolar-specific absolute estimate was approximately 13%, with relative risk approximately 9. These figures describe different sets of studies and ascertainment strategies. They are not competing estimates of one precisely known personal probability.
The meta-analysis found considerable between-study variation, and 96% of included studies had a high risk of bias in at least one assessed domain. Family high-risk research may recruit particularly affected families and use intensive structured assessment; registries often capture a broader population but miss some diagnoses. Consequently, 5% and 13% should be presented as study-derived group estimates with methodological qualifications rather than individual predictions Uher et al., 2023.
The durable clinical conclusion is that having an affected parent significantly raises average risk, while most offspring do not develop bipolar disorder. The person's age, symptoms, additional family diagnoses, and clinical setting remain necessary when interpreting that risk.
What if one parent has bipolar I or bipolar II?
Both bipolar I and bipolar II involve elevated familial susceptibility, but it is not possible to infer a child's precise risk or future subtype simply from the parent's diagnostic label. Bipolar I is defined by the occurrence of mania, whereas bipolar II requires hypomania and major depressive episodes without a history of full mania. Bipolar II can be seriously disabling and should not be described as a mild form of bipolar I NIMH.
Modern genomic research finds overlapping genetic influences as well as differences among bipolar subtypes and ascertainment groups. Those group-level observations do not support a simple rule that bipolar I parents transmit bipolar I and bipolar II parents transmit bipolar II O'Connell et al., 2025.
What if both parents have bipolar disorder?
The presence of more than one affected close relative may indicate greater familial burden, but research does not establish a single universally applicable percentage for the child of two affected parents. Such a calculation depends on family recruitment, diagnostic ascertainment, age at follow-up, and correlated inherited and environmental exposures. Multiplying two one-parent figures, or adding their percentages, would be misleading.
The National Library of Medicine notes that familial risk differs across families. Clinicians can discuss the observed family pattern, the limits of available evidence, and options for genetic counseling without claiming the certainty of a numeric result that has not been established for that particular family.
Does having an affected sibling change risk?
Yes. A full sibling is a first-degree relative, as are parents and children. The increased risk is relevant to clinical history, but siblings do not inherit identical combinations of variants and do not necessarily experience the same environmental or developmental conditions. A sibling's diagnosis may warrant greater clinical attention to sustained symptoms; it is not evidence of an existing disorder in another sibling MedlinePlus Genetics.
Does a grandparent, aunt, uncle, or cousin count?
Information about more distant relatives can contribute to a family history, especially when multiple relatives have experienced clear mania, recurrent severe mood episodes, or hospital treatment. Such relationships generally carry less predictive information than an affected first-degree relative considered alone. Historical psychiatric diagnoses can also be imprecise, and family members may have received care under older terminology.
A useful clinical pedigree therefore distinguishes formal diagnoses from family descriptions of behavior and records degrees of relationship rather than assuming that every instance of “mood swings” represents bipolar disorder. The NICE assessment guideline recommends documenting psychiatric family history within a much broader assessment.
Can bipolar disorder occur without family history?
Yes. Many people with bipolar disorder have no known relative with the same diagnosis. Genetic susceptibility exists on a continuum in the wider population, and a person's combination of variants can differ from the combinations inherited by siblings. Some relatives may remain well, some may develop different psychiatric conditions, and others may have never received an assessment.
An absent family history is also subject to missing information: adoption, early death, stigma, inaccessible records, changing classifications, and unrecognized hypomania can all affect what is known. Clinicians therefore cannot rule out bipolar I or bipolar II merely because a person cannot identify an affected relative. The diagnosis depends on actual episodes and their longitudinal course NIMH, NICE.
Can bipolar disorder skip a generation?
A family may appear to have bipolar disorder in a grandparent and grandchild without a diagnosis in the intervening parent. This does not imply a special gene that switches on every other generation. Bipolar disorder generally lacks the simple inheritance pattern found in certain single-gene conditions.
An individual can inherit susceptibility yet never experience a qualifying clinical episode. A family member may experience depression or another psychiatric presentation rather than bipolar disorder, or an episode may never have been recognized. Thus familial liability can be transmitted with variable expression, and the appearance of a skipped generation is compatible with complex inheritance MedlinePlus Genetics.
What do twin studies reveal?
Twin studies compare the co-occurrence of bipolar disorder among identical and fraternal twin pairs. Identical twins share nearly all their inherited DNA sequence, while fraternal twins on average share about half of their segregating inherited variants. Higher concordance among identical twins supports a genetic contribution, although estimating its magnitude depends on assumptions concerning environmental similarity and other factors.
In a Finnish population-based study that used structured interviews, probandwise concordance for bipolar I was estimated at 0.43 among identical twins and 0.06 among fraternal twins. The confidence intervals were wide, reflecting a small number of relevant pairs. The authors estimated high heritability, but that particular study's estimate should be interpreted within its design rather than treated as a universal individual-level statistic Kieseppä et al., 2004.
The most important observation for families is that identical twins can have different outcomes. Strong inherited influences and incomplete concordance are entirely compatible. Twin findings support genetic liability without establishing that any one genotype guarantees illness NIMH.
How many genes are associated with bipolar disorder?
Many. Bipolar disorder is highly polygenic, meaning that susceptibility is distributed across numerous genomic variants, usually with very small individual effects. Rare genetic variants may contribute in particular cases, but evidence does not establish one bipolar gene that explains the disorder in most affected families.
The largest relevant research advance is the 2025 multi-ancestry genome-wide association meta-analysis in Nature. The investigators analyzed 158,036 bipolar cases and 2,796,499 controls across 79 cohorts, identifying 298 genomic loci associated with the disorder. They prioritized 36 genes through additional statistical and mapping analyses and found evidence implicating some neuronal cell populations.
An associated locus is a statistical genomic region. It is not automatically the causal mutation or a clinically validated disease gene. Likewise, prioritizing a gene does not demonstrate that its effect is individually deterministic. Moving from association to mechanism requires independent work on gene expression, cell biology, developmental processes, and reproducible clinical outcomes.
What is a GWAS?
A genome-wide association study, or GWAS, compares large numbers of genetic variants across people with and without an outcome. Researchers look for variants that differ in frequency beyond levels expected by chance, while adjusting for population structure and the many simultaneous tests. Individual effect sizes are usually small, making large samples and replication central to reliable discovery.
A study can reveal robust associations without offering a clinical prediction model. The 2025 Nature study included clinical, community-record, and self-reported bipolar groups and reported genetic differences according to case ascertainment and subtype. The findings improve biological research but do not eliminate uncertainty arising from diagnostic heterogeneity or ancestry differences.
What are polygenic variants doing in the brain?
Researchers study how associated genetic differences influence gene regulation, neurodevelopment, cell signaling, and activity in neuronal systems. The 2025 study reported enrichment of signals in brain cell classes that included GABAergic interneurons and medium spiny neurons. Such findings generate mechanistic hypotheses that scientists must test; they do not provide a brain scan or blood assay that independently diagnoses bipolar disorder O'Connell et al., 2025.
Why more associated genes do not mean a predictable illness
A person's genotype is present long before most psychiatric symptoms emerge. It cannot currently tell a clinician when a manic or depressive episode will begin, its duration, the degree of functional impairment, or which treatment will be effective. The genetic architecture of bipolar disorder is informative at the population level, while individual diagnosis still requires observation of the person's actual clinical course.
This distinction also matters for scientific communication. The 298 identified loci are research findings, not 298 separate clinical diagnostic tests. The gap between variant discovery and reliable personalized care remains substantial ISPG.
Do bipolar I and bipolar II share genetic risk?
Yes, genetic influences overlap substantially. Researchers also investigate differences between diagnostic subtypes. The 2025 Nature study found variation in genetic architecture between bipolar I and bipolar II datasets, with ascertainment methods contributing to measured differences. These are population findings requiring continued validation.
Clinical subtype remains defined by the person's episodes. Mania and hypomania differ in severity, duration, impairment, and clinical consequences, and bipolar II involves substantial depressive morbidity. A relative's bipolar subtype or a research polygenic risk score is insufficient to classify an individual's disorder NIMH.
Research results focused on bipolar I and bipolar II also should not be automatically generalized with identical precision to cyclothymic disorder or other specified bipolar presentations. These conditions require separate clinical and research consideration.
Why do depression and other disorders appear in the same family?
Genetic factors contributing to bipolar susceptibility can overlap with those involved in some other psychiatric conditions. Family members may have bipolar disorder, major depressive disorder, schizophrenia-spectrum illness, anxiety, or other conditions. Shared exposures and differences in diagnostic evaluation are also relevant, so family clustering cannot be interpreted as purely genetic transmission of one clinical label.
The 2023 World Psychiatry synthesis examined both same-disorder and cross-disorder risks among offspring of affected parents. Across relevant data, the pooled absolute risk of any mental disorder for offspring of parents with bipolar disorder was estimated around 55%, compared with around 14% among offspring of parents without those psychiatric diagnoses. This 55% figure concerns all mental disorders and is emphatically not the probability of bipolar disorder itself. Its size is influenced by study selection and follow-up.
A family history of depression can therefore be relevant to evaluating bipolar symptoms but never substitutes for identifying mania or hypomania. Differential diagnosis must distinguish bipolar depression from unipolar depression and evaluate other explanations such as substance effects, thyroid conditions, ADHD, psychotic disorders, and medication-related changes NICE CG185.
How do genetics and environment interact?
Genetic risk develops within a lifelong context that includes biological development, health conditions, experiences, and social circumstances. Studies have associated bipolar disorder or episodes with stressful experiences, trauma, sleep or circadian disturbance, substance exposure, and other factors. The evidence for each potential influence differs, and an observed association should not automatically be interpreted as proof of a distinct causal pathway. For the larger clinical mechanisms map, see What Causes Bipolar Disorder? Genetics, Biology, and Environmental Factors.
The NIMH bipolar overview explains inherited and environmental contributions; MedlinePlus Genetics likewise describes complex relationships with stressful events and other exposures. Such evidence provides no basis for blaming a person, their parenting, or their family for the appearance of an illness.
Does stress activate a bipolar gene?
Claims that one stressful event “switches on” a bipolar gene compress a complex scientific question into an unsupported metaphor. Researchers examine gene–environment interaction, epigenetic processes, and stress-related biological systems, but current evidence does not allow clinicians to trace a bipolar diagnosis to a particular episode of stress activating a known gene.
Stressful events are still relevant in psychiatric assessment because they may precede symptoms, affect functioning, or complicate care. Their temporal relationship to symptoms should be explored rather than transformed into an assured molecular explanation NIMH.
What role does sleep play?
Sleep changes are clinically important. A markedly reduced need for sleep can be part of mania or hypomania; irregular rhythms can also be relevant to relapse and the broader course of established bipolar disorder. Family members may notice abrupt shifts in sleep, energy, and behavior and contribute useful observations to an assessment NIMH.
Regular routines and attention to sleep may support management and relapse prevention. This does not establish that a particular sleep schedule guarantees primary prevention of bipolar disorder in an unaffected genetically susceptible child. Evidence from treatment of diagnosed illness must not be reused as proof of prevention NICE.
Do alcohol or drugs matter?
Substance use can affect sleep, mood, judgment, and psychiatric symptoms and may complicate the differential diagnosis of manic or depressive presentations. Clinicians review exposure histories because some substances and medications can produce mood symptoms that resemble bipolar episodes. Assessing substance-related symptoms is especially important when a family history raises concern but the person's longitudinal pattern remains unclear NIMH, NICE.
Is there a genetic test for bipolar disorder?
There is currently no routine clinical genetic test that can establish bipolar I or bipolar II, exclude those diagnoses, or reliably tell an otherwise healthy person whether they will develop the condition. Psychiatric genetics has identified numerous associations, yet they are neither collectively nor individually equivalent to a definitive clinical test.
The International Society of Psychiatric Genetics genetic testing statement describes polygenic risk scores as research analyses and states they are not recommended for clinical use to identify high-risk individuals or help diagnose psychiatric patients. The NIMH guide to mental-health genetics explains why genetic information for common psychiatric conditions remains limited as an individual predictor.
Commercial offerings may emphasize a genetic percentile or selected risk variants. Such results depend on the study population, weighting model, included variants, ancestry, and reference group. They cannot determine whether current symptoms meet clinical criteria and should not direct medication or family-planning decisions without qualified interpretation.
What is a polygenic risk score?
A polygenic risk score combines weighted signals from many variants to produce a summary measure of inherited susceptibility within a statistical model. Researchers test whether it improves prediction beyond clinical and family-history factors. A higher score can shift average risk in a study group, but it does not identify a person who inevitably develops bipolar disorder.
The 2025 Nature study found that genetic architecture differed by case ascertainment, subtype, and some ancestry comparisons. These differences create important validation challenges. Scores developed in one population can perform differently elsewhere; translating rankings into reliable absolute risk requires prospective studies and careful calibration.
Can a negative test rule out bipolar disorder?
No. A low score or an absence of selected variants cannot exclude a future disorder, just as a high score cannot confirm one. Clinical assessment remains based on episodes, their duration and impact, alternative causes, and the person's longitudinal history NICE CG185.
When is genetic counseling useful?
Genetic counseling can help an individual or family understand what inherited susceptibility means, where estimates came from, how uncertain personal predictions remain, and why a consumer genetic report should be interpreted cautiously. It can also support discussions about reproductive decisions and family concerns. Referral is especially relevant when someone is distressed by inherited-risk claims or has questions about other genetic conditions that require separate testing.
A specialist might recommend evaluation for a different genetic syndrome when additional neurological, developmental, or physical findings suggest one. That is a separate clinical indication and should not be confused with routine bipolar susceptibility testing ISPG.
Is family history used in bipolar diagnosis?
Family history is a meaningful part of diagnosis, but it is only one part. A qualified clinician investigates whether the person experienced clinical episodes of mania, hypomania, and depression; how long they lasted; what changes occurred in activity, energy, and sleep; whether there was significant impairment; and how the person's condition changed over time. The comprehensive disorder overview is available in Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment.
The NICE bipolar guideline, updated in 2025, recommends a detailed history of mood and activity episodes, inter-episode symptoms, triggers, relapse patterns, family history, psychosocial circumstances, comorbidities, medical health, medications, and corroborative history when appropriate. NIMH similarly emphasizes lifetime symptom severity, frequency, and duration NIMH.
A parent with bipolar disorder may increase clinical suspicion when an adult presents with recurrent depression and previous periods of unusually high energy or reduced need for sleep. Nevertheless, an online questionnaire, family narrative, or genetic profile alone cannot establish a diagnosis. Relevant distinctions include bipolar depression versus unipolar depression, ADHD symptoms versus sustained mood episodes, psychosis related to mood episodes, substance-induced symptoms, and medical mimics.
How to prepare a family history
Write down which relatives have confirmed diagnoses, their relationship to you, approximate age of onset, notable manic or depressive episodes if reliably known, and any major hospitalizations. If details are uncertain, record the uncertainty instead of guessing. This information should be collected with respect for relatives' privacy.
For personal symptoms, document distinct periods of change in sleep, activity, mood, speech, judgment, social or work functioning, and any medical or substance factors. With consent, someone who observed these changes may contribute additional information. Such history directly supports the clinical evaluation recommended by NICE.
What does inherited risk mean for children and teenagers?
An affected parent raises a child's statistical risk, but it does not establish childhood bipolar disorder. Irritability, rapid emotional changes, impulsivity, sleep resistance, or unusual energy can occur for many developmental and clinical reasons. Diagnosis requires developmental context, clearly characterized mood episodes, effects on functioning, longitudinal follow-up, and expert differentiation from other conditions.
Importantly, NICE CG185 advises against diagnosing bipolar disorder in children or young people solely on the combination of depression and a bipolar family history; appropriate clinical follow-up may be indicated. Research estimates from adult clinical samples should not be transferred automatically to children.
The 2023 family high-risk review also shows why observation age matters: psychiatric outcomes can emerge as offspring grow older, and prospective follow-up differs from a one-time screen. The useful response is supportive attention to meaningful, persistent changes and timely assessment when needed, not assigning an illness to an unaffected child.
Should children be given preventive bipolar medication because of family history?
A family history by itself is not an indication to prescribe lithium, lamotrigine, valproate, antipsychotics, antidepressants, or other psychiatric medications to a well child. Medication decisions require a clinical indication, careful benefit–harm assessment, age-appropriate evidence, and qualified care. Recommendations for acute mania, bipolar depression, or maintenance treatment cannot be converted into preventive drug recommendations for asymptomatic relatives NICE.
Family planning when bipolar disorder runs in the family
People with bipolar disorder and their partners can discuss inherited susceptibility without treating it as a certain outcome for a future child. Group-level research helps explain elevated probability, but it does not forecast a particular child's diagnosis or severity. A discussion with a genetic counselor or mental-health professional can clarify what family history does and does not reveal MedlinePlus Genetics.
Pregnancy and postpartum psychiatric care is a separate clinical field with important medication and safety considerations. People planning pregnancy or currently pregnant should discuss medication and relapse risks with a specialist before making treatment changes. Lithium, valproate, lamotrigine, antipsychotics, and other treatments have distinct indications, contraindications, monitoring requirements, and reproductive considerations. The NICE guideline directs clinicians to specialized antenatal and postnatal guidance. Genetics does not justify abruptly starting, stopping, or adjusting a prescribed medication.
Can bipolar disorder be prevented in a genetically susceptible person?
No intervention is established to guarantee that an unaffected person with increased genetic liability will never develop bipolar disorder. Research on early recognition and targeted preventive interventions continues. A high family-risk group remains heterogeneous: many people remain well, and the future clinical course cannot be specified from heredity alone.
Reasonable practical measures include knowing relevant family health information, obtaining clinical help for persistent symptoms, supporting regular sleep and a healthy routine, and addressing substance misuse or other health concerns. They are appropriate aspects of general health and, when a person already has bipolar disorder, of ongoing management. They should not be advertised as proven techniques to eliminate inherited risk NIMH, NICE. This separation of prevention from treatment is consistent with the CANMAT/ISBD guidance for bipolar illness phases, which evaluates evidence separately for acute mania, bipolar depression, and longer-term maintenance, rather than treating those recommendations as medication indications for unaffected relatives.
For people with an established diagnosis, evidence-based treatment and relapse prevention are important. Clinical care may include medication, structured psychotherapy, family psychoeducation, monitoring, and collaborative planning according to illness phase and individual needs. Response to treatment cannot be inferred from the amount of genetic risk assumed to be present VA/DoD guideline.
When does family history justify clinical evaluation?
Sharing a known family history with a healthcare professional is appropriate when someone experiences recurrent depression, sustained shifts in energy or sleep, unusual overactivity or disinhibition, serious impairment, or other concerning changes. Clinicians can then evaluate the pattern over time and investigate alternative explanations.
An urgent assessment is warranted when someone has markedly reduced need for sleep accompanied by escalating activity and impaired judgment, dangerous or uncharacteristic behavior, psychotic symptoms, severe depression, inability to care for basic needs, or suicidal thinking. These situations call for clinically appropriate assessment regardless of whether there is a family history. For immediate danger, use local emergency services. In the United States, the 988 Suicide and Crisis Lifeline is available by calling or texting 988 NIMH.
Strengths and limits of the scientific evidence
Evidence that bipolar disorder has a substantial inherited component is established across multiple lines of research. Important uncertainty concerns individualized risk, the contribution of specific variants, differences across ancestry groups and clinical subtypes, and the biological pathways connecting genes with episodes.
The 2025 genomic meta-analysis greatly expands associated-locus discovery but does not deliver clinically validated individual prediction. The 2023 family meta-analysis provides important absolute and relative risk comparisons yet reports substantial heterogeneity and widespread risk of bias. Smaller twin studies offer independent support for inherited liability while their confidence intervals remind readers that an estimate is subject to sampling uncertainty Kieseppä et al., 2004.
As research develops, more robust multi-ancestry datasets, prospective outcome studies, reliable phenotype definitions, and meaningful clinical validation are essential. Genetic research can contribute to understanding bipolar disorder long before its findings are suitable as diagnostic or predictive services ISPG.
Common misconceptions
“Bipolar disorder is 80% genetic, so my child has an 80% chance of developing it.” This substitutes a population heritability estimate for absolute offspring risk. They are different measures O'Connell et al., 2025, Uher et al., 2023.
“No family history means bipolar disorder is impossible.” Polygenic susceptibility can occur without known diagnosed relatives, and diagnostic assessment depends on actual episodes MedlinePlus Genetics.
“Bipolar II is a milder inherited version of bipolar I.” Bipolar II has its own episode criteria and can carry substantial depression-related disability. Genomic subtype associations do not replace clinical diagnosis NIMH.
“A consumer test can tell me if I will become bipolar.” Current polygenic risk scores are not recommended for clinical diagnosis or identifying high-risk individuals ISPG.
“High genetic risk means treatment cannot work.” Established clinical approaches support symptom management, functioning, and relapse prevention regardless of a person's family background NICE.
Frequently asked questions
If my mother or father has bipolar disorder, will I get it?
Most offspring of an affected parent do not develop the same diagnosis. A major 2023 meta-analysis found roughly fivefold elevated relative risk, with absolute estimates that varied between broad mixed-design data and age-appropriate prospective cohorts. These estimates are for research groups and cannot determine a particular person's outcome Uher et al., 2023.
Is bipolar disorder inherited from the mother's side or father's side?
Bipolar disorder generally follows a complex polygenic pattern. Both parents contribute inherited variation, and a family history on either side can be relevant. There is no established rule that ordinary bipolar disorder is transmitted only through mothers or only through fathers MedlinePlus Genetics.
Can two siblings have different bipolar risk?
Yes. Siblings can inherit different combinations of risk-associated genetic variants and have different developmental histories. Even identical twins can be discordant for bipolar disorder, demonstrating why shared heredity does not ensure shared clinical outcomes Kieseppä et al., 2004.
Can someone pass bipolar genes to a child without having bipolar disorder?
People without bipolar disorder can carry many variants statistically associated with bipolar susceptibility. The complex inheritance pattern does not require every generation to include a clinically affected person. The language of “carrying the bipolar gene” is misleading because no single variant accounts for the ordinary condition NIMH.
Is having a parent with depression the same as having a parent with bipolar disorder?
No. Different parental diagnoses can carry partly overlapping but different familial risks. Depression in a relative is not proof that the relative has bipolar disorder or that the offspring has inherited a bipolar diagnosis. Clinical assessment depends on actual lifetime mood episodes NICE, Uher et al., 2023.
Can genetic tests distinguish bipolar I from bipolar II?
No currently established routine test assigns an individual's bipolar subtype from DNA. Although modern research detects subtype-associated differences, clinical classification relies on the presence of mania, hypomania, depressive episodes, and their longitudinal course O'Connell et al., 2025, NIMH.
Is bipolar disorder present at birth?
Some susceptibility is inherited from conception, but clinical bipolar disorder is identified through actual mood episodes, which generally arise later in development. Inherited liability should not be interpreted as a diagnosis in an unaffected newborn NIMH.
Should a child with bipolar family history have routine DNA screening?
Current psychiatric polygenic tests are not recommended for routine diagnosis or identification of high-risk individuals. When significant clinical symptoms occur, a developmentally appropriate mental-health assessment is more informative. The NICE guideline also cautions against diagnosing bipolar disorder in a child on the basis of depression and family history alone ISPG, NICE.
Does a high genetic risk mean I should take medication?
No. Clinical treatment requires a diagnosis, an appropriate indication, and an individualized benefit–risk assessment. Do not begin, stop, or alter a prescribed psychiatric medication based on a consumer genetic report or family-risk percentage ISPG, NICE.
Conclusion
Bipolar disorder has a substantial inherited component, established by family, twin, and modern genomic research. Its genetic architecture is complex and polygenic. Having an affected first-degree relative increases the probability of a future diagnosis but never predetermines the outcome. Population heritability figures such as 60%–80% must be interpreted separately from the absolute risk observed among offspring of affected parents.
The most useful clinical response to a family history is accurate information, a longitudinal account of real symptoms, and timely professional assessment when meaningful episodes emerge. Current DNA tests cannot replace these steps. Large genetic studies are expanding scientific knowledge, while individualized psychiatric prediction remains an important research goal O'Connell et al., 2025, Uher et al., 2023.
Related Articles
References
International Society of Psychiatric Genetics. (2019; current online guidance). Genetic testing statement. https://ispg.net/genetic-testing-statement/.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009
Kieseppä, T., Partonen, T., Haukka, J., Kaprio, J., & Lönnqvist, J. (2004). High concordance of bipolar I disorder in a nationwide sample of twins. American Journal of Psychiatry, 161(10), 1814–1821. https://doi.org/10.1176/ajp.161.10.1814.
National Institute for Health and Care Excellence. (2014; updated September 2025). Bipolar disorder: Assessment and management (CG185). https://www.nice.org.uk/guidance/cg185/chapter/recommendations.
National Institute of Mental Health. (2025). Bipolar disorder (NIH Publication No. 25-MH-8088). https://www.nimh.nih.gov/health/publications/bipolar-disorder.
National Institute of Mental Health. (n.d.). Looking at my genes: What can they tell me about my mental health? https://www.nimh.nih.gov/health/publications/looking-at-my-genes.
National Library of Medicine. (n.d.). Bipolar disorder. MedlinePlus Genetics. https://medlineplus.gov/genetics/condition/bipolar-disorder/.
O'Connell, K. S., Koromina, M., van der Veen, T., et al. (2025). Genomics yields biological and phenotypic insights into bipolar disorder. Nature, 639, 968–975. https://doi.org/10.1038/s41586-024-08468-9.
Uher, R., Pavlova, B., Radua, J., et al. (2023). Transdiagnostic risk of mental disorders in offspring of affected parents: A meta-analysis of family high-risk and registry studies. World Psychiatry, 22(3), 433–448. https://doi.org/10.1002/wps.21147.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of bipolar disorder. https://www.healthquality.va.gov/guidelines/MH/bd/.